File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study

TitleDevelopment of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study
Authors
KeywordsAnxiety
Anxiety disorder
Cannabis
Cannabis use disorder
Cohort study
Health administrative data
Issue Date2024
Citation
eClinicalMedicine, 2024, v. 69, article no. 102455 How to Cite?
AbstractBackground: There is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. In this study we estimated the risk of having an incident healthcare visit for an anxiety disorder following an emergency department (ED) visit for cannabis use and explored factors associated with increased risk. Methods: We used health administrative data to perform a population-based cohort study of all individuals aged 10–105 years with no previous healthcare visits for anxiety disorders in Ontario, Canada, between January 2008 and March 2019. We compared the risk of having an incident healthcare visit for an anxiety disorder in the ED or hospital (primary analysis) or additionally in an outpatient setting (secondary analysis) for individuals with an incident ED visit for cannabis to members of the general population using cumulative incidence functions and cause-specific hazard models adjusted for relevant confounders. Findings: Our study included 12,099,144 individuals aged 10–105 without prior care for an anxiety disorder in the ED or hospital, of which 34,822 (0.29%) had an incident ED visit due to cannabis. Within 3-years of an incident ED visit due to cannabis, 12.3% (n = 4294) of individuals had an incident ED visit or hospitalization for an anxiety disorder—a 3.7-fold (adjusted Hazard Ratio [aHR] 3.69 95% CI 3.57–3.82) increased risk relative to the general population (1.2%). In secondary analysis, further excluding individuals with prior outpatient care for anxiety disorders, 23.6% of individuals with an ED visit due to cannabis had an incident outpatient visit, ED visit, or hospitalization for an anxiety disorder within 3-years compared to 5.6% of individuals in the general population (aHR 3.88 95% CI 3.77–2.99). The risk of having an incident healthcare visit for an anxiety disorder was higher in individuals with ED visits for cannabis use compared to the general population across all age and sex strata. However, younger males with ED visits for cannabis use (aHR 5.67 95% CI 5.19–6.21) had a greater risk relative to the general population than younger women with cannabis use (aHR 3.22 95% CI 2.95–3.52). Interpretation: ED visits for cannabis use were associated with an increased risk of having an incident healthcare visit for an anxiety disorder, particularly in young males. These findings have important clinical and policy implications given the increasing use of cannabis over time and trend towards legalization of cannabis. Funding: Canadian Institutes for Health Research.
Persistent Identifierhttp://hdl.handle.net/10722/347109

 

DC FieldValueLanguage
dc.contributor.authorMyran, Daniel T.-
dc.contributor.authorHarrison, Lyndsay D.-
dc.contributor.authorPugliese, Michael-
dc.contributor.authorTanuseputro, Peter-
dc.contributor.authorGaudreault, Adrienne-
dc.contributor.authorFiedorowicz, Jess G.-
dc.contributor.authorSolmi, Marco-
dc.date.accessioned2024-09-17T04:15:27Z-
dc.date.available2024-09-17T04:15:27Z-
dc.date.issued2024-
dc.identifier.citationeClinicalMedicine, 2024, v. 69, article no. 102455-
dc.identifier.urihttp://hdl.handle.net/10722/347109-
dc.description.abstractBackground: There is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. In this study we estimated the risk of having an incident healthcare visit for an anxiety disorder following an emergency department (ED) visit for cannabis use and explored factors associated with increased risk. Methods: We used health administrative data to perform a population-based cohort study of all individuals aged 10–105 years with no previous healthcare visits for anxiety disorders in Ontario, Canada, between January 2008 and March 2019. We compared the risk of having an incident healthcare visit for an anxiety disorder in the ED or hospital (primary analysis) or additionally in an outpatient setting (secondary analysis) for individuals with an incident ED visit for cannabis to members of the general population using cumulative incidence functions and cause-specific hazard models adjusted for relevant confounders. Findings: Our study included 12,099,144 individuals aged 10–105 without prior care for an anxiety disorder in the ED or hospital, of which 34,822 (0.29%) had an incident ED visit due to cannabis. Within 3-years of an incident ED visit due to cannabis, 12.3% (n = 4294) of individuals had an incident ED visit or hospitalization for an anxiety disorder—a 3.7-fold (adjusted Hazard Ratio [aHR] 3.69 95% CI 3.57–3.82) increased risk relative to the general population (1.2%). In secondary analysis, further excluding individuals with prior outpatient care for anxiety disorders, 23.6% of individuals with an ED visit due to cannabis had an incident outpatient visit, ED visit, or hospitalization for an anxiety disorder within 3-years compared to 5.6% of individuals in the general population (aHR 3.88 95% CI 3.77–2.99). The risk of having an incident healthcare visit for an anxiety disorder was higher in individuals with ED visits for cannabis use compared to the general population across all age and sex strata. However, younger males with ED visits for cannabis use (aHR 5.67 95% CI 5.19–6.21) had a greater risk relative to the general population than younger women with cannabis use (aHR 3.22 95% CI 2.95–3.52). Interpretation: ED visits for cannabis use were associated with an increased risk of having an incident healthcare visit for an anxiety disorder, particularly in young males. These findings have important clinical and policy implications given the increasing use of cannabis over time and trend towards legalization of cannabis. Funding: Canadian Institutes for Health Research.-
dc.languageeng-
dc.relation.ispartofeClinicalMedicine-
dc.subjectAnxiety-
dc.subjectAnxiety disorder-
dc.subjectCannabis-
dc.subjectCannabis use disorder-
dc.subjectCohort study-
dc.subjectHealth administrative data-
dc.titleDevelopment of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.eclinm.2024.102455-
dc.identifier.scopuseid_2-s2.0-85188013636-
dc.identifier.volume69-
dc.identifier.spagearticle no. 102455-
dc.identifier.epagearticle no. 102455-
dc.identifier.eissn2589-5370-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats